|
|
|
|
|
|
|
|
|
|
Super Quote | Detail Quote | Interactive Chart | Transaction | Related News | Related Securities | Company Information | Dividend Records | Short Sell
02186 LUYE PHARMA
Nominal 
4.030 +0.170 (+4.404%) Ranking Overview
Ranking based on 3 research report(s)
Average Ranking 3.00
|
Strong Buy (1)
0
|
Buy (2)
1
|
Hold (3)
1
|
Sell (4)
1
|
Strong Sell (5)
0
|
Previous Financial Performance
| Financial Year | 12/2024 | EPS | 12.54 RMB (cts) | |
| Net Profit | 471.89 RMB (MIL) | DPS | 0.00 RMB (cts) |
Consolidation Estimation
| Financial Year | Profit / (Loss) (RMB (MIL)) |
EPS/ ((LPS)(RMB (cts)) |
DPS (RMB (cts)) |
Net Asset Value per Share (RMB) |
Highest (RMB (MIL)) |
Lowest (RMB (MIL)) |
| 2025 | 740.70 | 20.00 | 0 | -- | 1,016.00 | 575.00 |
| 2026 | 1,083.90 | 29.00 | 0 | -- | 1,163.00 | 735.00 |
| 2027 | 898.00 | 24.00 | 0 | -- | 898.00 | 898.00 |
Profit Estimation
| Profit Estimation | Profit / (Loss) (RMB (MIL)) |
EPS*/ (LPS) (RMB (cts)) |
DPS * (RMB (cts)) |
Broker | Ranking | Target Price* (HKD) |
Update Date | |
| 2025 | 740.70 | 20.00 | -- | GOLDMAN SACHS | Neutral | 3.13 | 13/03/2025 | |
| 2025 | 575.00 | 15.00 | -- | CITIGROUP | Buy | 3.10 | 02/04/2025 | |
| 2025 | 1,016.00 | 27.00 | -- | MORGAN STANLEY | Underweight | 3.00 | 31/03/2025 | |
| 2026 | 1,083.90 | 29.00 | -- | GOLDMAN SACHS | -- | -- | 13/03/2025 | |
| 2026 | 735.00 | 20.00 | -- | CITIGROUP | -- | -- | 02/04/2025 | |
| 2026 | 1,163.00 | 31.00 | -- | MORGAN STANLEY | -- | -- | 31/03/2025 | |
| 2027 | 898.00 | 24.00 | -- | CITIGROUP | -- | -- | 02/04/2025 | |
| Remarks: | Average rating ranges from 1 to 5. The lower the figure, the higher the rating and the vice versa. |
| *EPS, DPS and Estimated Price would be adjusted upon Consolidation, Split and Bonus Issue | |
| Real time quote last updated: 25/07/2025 13:05 | |
| Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service | |